Company: WHWK
Filing Date: 2025-01-21
Form Type: PREM14A
Source: 0001193125-25-009599
Chunk: 117

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-21
Form: PREM14A
Chunk 117
---
 as of 12:01 a.m. Pacific time on the date of completion of the Divestiture (the “Measurement Time”), 
 minus (2) the amount of any overdrafts and any amounts required to cover checks, wires and similar instruments issued by Aadi Sub which have not cleared as of the Measurement Time;                                                       |

| • |     | an adjustment for indebtedness of Aadi Sub determined and valued as of the Measurement Time in accordance with 
 GAAP in a manner consistent with Aadi’s accounting policies and historical accounting practices;               |

| • |     | an adjustment for certain transaction expenses incurred in connection with the Divestiture; |

| • |     | a working capital adjustment, subject to a dollar range (the “Net Working Capital Range”) from and                                                                                                                                                     
 including $1.6 million (the “Net Working Capital Floor”) to and including $3.14 million (the “Net Working Capital Ceiling”), based on the amount by which the closing working capital of Aadi Sub as of the Measurement Time exceeds                   
 the Net Working Capital Ceiling or based on the amount by which the closing working capital of Aadi Sub as of the Measurement Time is less than the Net Working Capital Floor; provided, that if the closing working capital of Aadi Sub is (1) within 
 the Net Working Capital Range, (2) less than the Net Working Capital Floor, or (3) exceeds the Net Working Capital Ceiling, the working capital adjustment will be $0.                                                                                 |

The cash paid by Kaken at the completion of the Divestiture will be based on estimates of the foregoing amounts and will be subject to customary post-closing true-up. If a payment by Kaken or Aadi is required, such payment will be made within five business days following the date of finalization of the post-closing true-up. Representations and Warranties The Divestiture Agreement contains representations and warranties of Aadi, Aadi Sub and Kaken. Some of the representations and warranties in the Divestiture Agreement made by Aadi and Aadi Sub are qualified as to “materiality,” “Seller Material Adverse Effect,” “Company Material Adverse Effect” or similar terms or concepts. For purposes of this proxy statement and the Divestiture Agreement, (1) “Seller Material Adverse Effect” means any change, event, effect, development or occurrence (“Effect”) that, individually or taken together with all other Effects, prevents or could reasonably be expected to prevent Aadi from consummating the Divest